相关产品推荐更多 >

Amthamine dihydrobromide-Amthamine dihydrobromide
¥33
ExoStd™ Lyophilized Exosome Standard (30 µg, Human Saliva, 6 vials)/ExoStd™ Lyophilized Exosome Standard (30 µg, Human Saliva, 6 vials)/ExoStd™ Lyophilized Exosome Standard (30 µg, Human Saliva, 6 vials)
询价![13-{[(3-t-Boc)-2,2-二甲基-4S-苯基-1,3-恶唑烷啶-5R-基]甲酰基}-6a,7a-二羟基浆果赤霉素III,13-{[(3-t-Boc)-2,2-dimethyl-4S-phenyl-1,3-oxazolidin-5R-yl]formyl}-6a,7a-dihydroxy Baccatin III,CAS:](https://img1.dxycdn.com/2023/0423/638/6802757527223752163-14.jpg!wh200)
13-{[(3-t-Boc)-2,2-二甲基-4S-苯基-1,3-恶唑烷啶-5R-基]甲酰基}-6a,7a-二羟基浆果赤霉素III,13-{[(3-t-Boc)-2,2-dimethyl-4S-phenyl-1,3-oxazolidin-5R-yl]formyl}-6a,7a-dihydroxy Baccatin III,CAS:
¥11
双嘧达莫四-O-β-D-葡糖醛酸,Dipyridamole Tetra-O-β-D-glucuronide,CAS:
¥11
盐酸乙基胺碘酮-d4,Desethyl Amiodarone-d4 Hydrochloride,CAS:1189960-80-2
¥11
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
该DiscoveryProbe™ Clinical & FDA approved Drug Library产品的保存方式具体查看产品。
- 保质期:
1年
- 英文名:
DiscoveryProbe™ Clinical & FDA approved Drug Library
- 库存:
100
- 供应商:
艾美捷科技
- CAS号:
无
- 规格:
100uL/well(10 mM solution),96 Well Deep Well Plate
DiscoveryProbe™ Clinical & FDA approved Drug Library,DiscoveryProbe™ Clinical & FDA approved Drug Library,DiscoveryProbe™ Clinical & FDA approved Drug Library,DiscoveryProbe™ Clinical & FDA approved Drug Library
DiscoveryProbe™ Clinical & FDA approved Drug Library-DiscoveryProbe™ Clinical & FDA approved Drug Library
产品货号:APE-L1052-096
产品规格:100uL/well(10 mM solution),96 Well Deep Well Plate
2726个临床和FDA批准药物小分子的集合,提供冻干粉或DMSO溶液形式

Screening Library

DiscoveryProbe™ Clinical & FDA approved Drug Library-DiscoveryProbe™ Clinical & FDA approved Drug Library该DiscoveryProbe™ Clinical & FDA approved Drug Library产品的保存方式具体查看产品。
点击:DiscoveryProbe™ Clinical & FDA approved Drug Library-DiscoveryProbe™ Clinical & FDA approved Drug Library查看更详细产品说明,更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多APExBIO公司特色小分子抑制剂等产品评论,请点击查看艾美捷特色产品中心。
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验GPCR Signaling: Understanding the Pathway to Successful Drug Discovery
Modulators of G protein-coupled receptors (GPCRs) form a key area for the pharmaceutical industry, representing ˜27% of all Food and Drug Administration (FDA)-approved drugs. Consequently, there are a wide variety of in vitro plate-based
Sustained-Release Ocular Drug Delivery Systems: Bench to Bedside Development
The process of bringing a drug through early development and on through a successful clinical trials campaign is long and complex. This chapter provides an overview of the drug development process and some of the challenges and pitfalls
Traumatic brain injury is a significant disease affecting 1.4 to 2 million patients every year in the USA. Currently, there are no FDA-approved therapeutic remedies to treat TBI despite the fact that there have been over 200 clinical drug
技术资料暂无技术资料 索取技术资料







